文献速递心境障碍

药物与心理治疗序贯联合用于重性抑郁障碍的系统综述与荟萃分析

Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

汇总风险比为0.84(95%CI,0.74-0.94),提示序贯联合治疗在预防复发/再燃方面相对优于对照。

要点

  • 急性期药物治疗应答后序贯心理治疗与重性抑郁障碍复发/再燃风险降低相关。
  • 汇总复发/再燃风险比为0.84(95%CI,0.74-0.94),对象为成人缓解期重性抑郁障碍患者。
  • 序贯策略的预防价值依赖于残留症状减轻和/或心理幸福感提升。

核心结论

  • 急性期药物治疗应答后序贯整合心理治疗(单用或联合抗抑郁药)与重性抑郁障碍复发和再燃风险降低相关。
  • 序贯策略的预防价值依赖于残留症状的减轻和/或心理幸福感的提升。

研究设计与样本

  • 由2名评审独立筛选研究并独立完成数据提取与方法学质量评估,采用随机效应模型合并结果,并行敏感性分析与荟萃回归。

主要发现

  • 重性抑郁障碍复发/再燃的汇总风险比为0.84(95%CI,0.74-0.94),提示序贯联合治疗相对对照组在预防复发/再燃方面具有相对优势。
  • 主要结局为研究者定义的重性抑郁障碍复发或再燃率,取最长可获得随访时间点的数据。

关键数值与推荐

  • 复发/再燃汇总风险比0.84(95%CI,0.74-0.94),对应序贯治疗组1208例与对照组1075例成人重性抑郁障碍缓解期患者。

临床怎么用

  • 对急性期药物治疗应答的成人重性抑郁障碍缓解期患者,可考虑序贯整合心理治疗以降低复发/再燃风险。
  • 文中提供了在复发性重性抑郁障碍缓解期患者中实施序贯方法的步骤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The sequential model emerged from the awareness that the persistence of residual symptoms and the frequent occurrence of psychiatric comorbidity were both associated with poor long-term outcome of major depressive disorder (MDD). OBJECTIVE: To conduct an updated meta-analysis to examine the association of the sequential combination of pharmacotherapy and psychotherapy with reduced risk of relapse and recurrence in MDD. DATA SOURCES: Keyword searches were conducted in PubMed, PsycInfo, Web of Science, and the Cochrane Library from inception of each database through November 2019. Reference lists from relevant studies were examined using the following keywords: sequential treatment, drugs and psychotherapy, combined treatment, continuation or maintenance, relapse or recurrence and prevention, and depress* or major depress*, selecting adults and randomized controlled trials as additional limits. Authors of selected articles were contacted if needed. STUDY SELECTION: Randomized clinical trials examining the effectiveness of the sequential use of psychotherapy following response to acute-phase pharmacotherapy in the treatment of adult remitted patients with MDD were selected independently by 2 reviewers. DATA EXTRACTION AND SYNTHESIS: The methods used fulfilled the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Data extraction and methodologic quality assessment were conducted independently by the reviewers. Examination of the pooled results was performed based on the random-effects model. Heterogeneity between study results and likelihood of significant publication bias were assessed. Sensitivity analyses and meta-regressions were also run. MAIN OUTCOMES AND MEASURES: The primary outcome measures were relapse or recurrence rates of MDD, as defined by study investigators, at the longest available follow-up. RESULTS: Seventeen randomized clinical trials met criteria for inclusion in the meta-analysis, with 1 study yielding 2 comparisons (2283 patients overall, with 1208 patients in a sequential treatment arm and 1075 in a control arm). The pooled risk ratio for relapse/recurrence of MDD was 0.84 (95% CI, 0.74-0.94), suggesting a relative advantage in preventing relapse/recurrence for the sequential combination of treatments compared with control conditions. CONCLUSIONS AND RELEVANCE: The results of this systematic review and meta-analysis indicate that the sequential integration of psychotherapy following response to acute-phase pharmacotherapy, alone or combined with antidepressant medication, was associated with reduced risk of relapse and recurrence in MDD. The preventive value of the sequential strategy relies on abatement of residual symptoms and/or increase in psychological well-being. The steps for implementing the sequential approach in remitted patients with recurrent MDD are provided.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Guidi J, Fava GA. Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021. PMID: 33237285. doi:10.1001/jamapsychiatry.2020.3650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。